Prescribing of disease modifying agents in older adults with multiple sclerosis
Volume: 57, Pages: 103308 - 103308
Published: Jan 1, 2022
Abstract
The use of disease-modifying agents (DMAs) to treat Multiple Sclerosis (MS) in older adults is debated as the disease activity decreases with aging. However, limited data exist regarding prescribing patterns of DMAs among older adults with MS.To examine prescribing patterns of DMAs and the factors associated with DMA prescribing practices among older adults with MS using electronic medical records (EMR) data.A retrospective longitudinal cohort...
Paper Details
Title
Prescribing of disease modifying agents in older adults with multiple sclerosis
Published Date
Jan 1, 2022
Volume
57
Pages
103308 - 103308
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History